Ex vivo inhibition of HSP90 or STAT5 at least partially decreased survival and effector function of tumor-infiltrating Rig-I–/– CD8+ T cells (Supplemental Figure 7, E–H). The gene discussed is STAT5A; the disease is neoplasm.